Page last updated: 2024-08-23

bw-755c and 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate

bw-755c has been researched along with 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Metz, SA	1

Other Studies

1 other study(ies) available for bw-755c and 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate

Article	Year
Lipoxygenase inhibitors reduce insulin secretion without impairing calcium mobilization. Endocrinology, 1987, Volume: 120, Issue:6 Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Antimycin A; Arachidonate Lipoxygenases; Barium; Butylated Hydroxytoluene; Calcium; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Gallic Acid; Insulin; Insulin Secretion; Lipoxygenase Inhibitors; Male; Masoprocol; Phospholipases A; Potassium; Pyrazoles; Rats; Secretory Rate; Trifluoperazine	1987

Article

Year

Lipoxygenase inhibitors reduce insulin secretion without impairing calcium mobilization.

Endocrinology, 1987, Volume: 120, Issue:6

Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Antimycin A; Arachidonate Lipoxygenases; Barium; Butylated Hydroxytoluene; Calcium; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Gallic Acid; Insulin; Insulin Secretion; Lipoxygenase Inhibitors; Male; Masoprocol; Phospholipases A; Potassium; Pyrazoles; Rats; Secretory Rate; Trifluoperazine

1987